THE ROLE OF PROTEIN UBIQUITINATION IN NEURODEGENERATIVE DISEASE

被引:0
|
作者
MAYER, RJ
LOWE, J
LANDON, M
MCDERMOTT, H
LASZLO, L
机构
[1] UNIV NOTTINGHAM HOSP, QUEENS MED CTR, SCH MED, DEPT PATHOL, NOTTINGHAM NG7 2UH, ENGLAND
[2] EOTVOS LORAND UNIV, DEPT GEN ZOOL, H-1364 BUDAPEST 5, HUNGARY
来源
ACTA BIOLOGICA HUNGARICA | 1991年 / 42卷 / 1-3期
基金
英国惠康基金;
关键词
UBIQUITIN; ALZHEIMERS DISEASE; DIFFUSE LEWY BODY DISEASE; SCRAPIE; LYSOSOME;
D O I
暂无
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Ubiquitin immunocytochemistry with an antiserum which reacts with ubiquitin-protein conjugates demonstrates the presence of ubiquitinated proteins in filamentous inclusions found in neurones in the major human neurodegenerative diseases, i.e. Alzheimer's disease, diffuse Lewy body disease, motor neurone disease. Ubiquitin immunohistochemistry has revolutionized the neuropathological diagnosis of dementia showing that diffuse Lewy body disease is not, as previously supposed, a rare cause of dementia. The filamentous inclusions in neurones in the human neurodegenerative diseases can be divided into at least two types based on recent immunocytochemical studies. We have shown that a ubiquitin-carboxyl terminal hydrolase is present in Lewy bodies but not in neurofibrillary tangles in Alzheimer's disease. This observation is significant since it indicates that molecular pathological mechanisms in neurones in diffuse Lewy body disease are fundamentally different to Alzheimer's disease. Ubiquitin-protein conjugates are also found in vacuoles in areas of granulovacuolar degeneration in hippocampal neurones in Alzheimer's disease and in granulovacuoles in neurones of scrapie infected mouse brain. These locations suggest that ubiquitinated proteins are present in the lysosome-related system of neurones. We have recently shown that ubiquitin-protein conjugates are indeed enriched some 12-fold in the lysosomes of normal fibroblasts and lymphocytes.
引用
收藏
页码:21 / 26
页数:6
相关论文
共 50 条
  • [41] The Role of the SLC Transporters Protein in the Neurodegenerative Disorders
    Aykac, Asli
    Sehirli, Ahmet Ozer
    CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE, 2020, 18 (02) : 174 - 187
  • [42] ROLE OF α-ARRESTINS IN UBIQUITINATION AND PROTEIN HOMEOSTASIS AT THE PLASMA MEMBRANE
    Zbieralski, Kacper
    Wawrzycka, Donata
    POSTEPY BIOLOGII KOMORKI, 2020, 47 (03) : 287 - 306
  • [43] Unfolding the role of protein misfolding in neurodegenerative diseases
    Claudio Soto
    Nature Reviews Neuroscience, 2003, 4 : 49 - 60
  • [44] Protein Glutathionylation and Glutaredoxin: Role in Neurodegenerative Diseases
    Haseena, P. A.
    Diwakar, Latha
    Ravindranath, Vijayalakshmi
    ANTIOXIDANTS, 2022, 11 (12)
  • [45] Linear ubiquitination in immune and neurodegenerative diseases, and beyond
    Tokunaga, Fuminori
    Ikeda, Fumiyo
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2022, 50 (02) : 799 - 811
  • [46] Designer protein disaggregases to counter neurodegenerative disease
    Shorter, James
    CURRENT OPINION IN GENETICS & DEVELOPMENT, 2017, 44 : 1 - 8
  • [47] TATA-Binding protein in neurodegenerative disease
    Van Roon-Mom, WMC
    Reid, SJ
    Faull, RLM
    Snell, RG
    NEUROSCIENCE, 2005, 133 (04) : 863 - 872
  • [48] A transmembrane form of the prion protein in neurodegenerative disease
    Hegde, RS
    Mastrianni, JA
    Scott, MR
    DeFea, KA
    Tremblay, P
    Torchia, M
    DeArmond, SJ
    Prusiner, SB
    Lingappa, VR
    SCIENCE, 1998, 279 (5352) : 827 - 834
  • [49] Developing therapeutic protein disaggregases for Neurodegenerative Disease
    Lin, JiaBei
    Shorter, James
    FASEB JOURNAL, 2022, 36
  • [50] Engineering enhanced protein disaggregases for neurodegenerative disease
    Jackrel, Meredith E.
    Shorter, James
    PRION, 2015, 9 (02) : 90 - 109